Listed

DLH Holdings Corp.: Form 10-Q for the period ended Jun 30, 2023

Filed with the SEC on Aug 2, 2023 and accepted by EDGAR at Aug 2, 2023, 16:24 ET.

Share

Management's discussion and analysis

As filed, 43,980 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Forward-Looking and Cautionary Statements

You should read the following discussion in conjunction with the Consolidated Financial Statements and the notes to those statements included elsewhere in this Quarterly Report on Form 10-Q, as well as our Annual Report on Form 10-K for the year ended September 30, 2022, and in other reports we have subsequently filed with the SEC. This Quarterly Report on Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements contained in this Management’s Discussion and Analysis are forward-looking statements that involve risks and uncertainties. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward-looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this report include, among others, statements regarding benefits of the acquisition, estimates of future revenues, operating income, earnings, earnings per share, backlog, and cash flows. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements made in this report due to a variety of factors, including: the continuation of the novel coronavirus (“COVID-19”), including the measures to reduce its spread, and its impact on the economy and demand for our services, which are uncertain, cannot be predicted, and may precipitate or exacerbate other risks and uncertainties; the failure to achieve the anticipated benefits of our acquisition of GRSi or any future acquisition (including anticipated future financial operating performance and results); the diversion of management’s attention from normal daily operations of the business and the challenges of managing larger and more widespread operations resulting from our recent acquisition; the inability to retain employees and customers; contract awards in connection with re-competes for present business and/or competition for new business; our ability to manage our increased debt obligations; compliance with bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; the ability to successfully integrate the operations of GRSi or any future acquisitions; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2022, as well as interim quarterly filings thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business. Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements.

Business and Markets Overview

DLH enhances public health and national security readiness missions through science, technology, cyber, and engineering solutions and services. We are primarily focused on improving and better deploying large-scale federal health and human service initiatives. The Company derives 99% of its revenue from agencies of the Federal government, providing services to several agencies including the Department of Veteran Affairs ("VA"), Department of Health and Human Services ("HHS"), Department of Defense ("DoD"), and Department of Homeland Security, ("DHS"). The following table summarizes revenue by customer for the three months ended June 30, 2023 and 2022 as follows (in thousands and percent):

2023 Revenue Percent of total revenue 2022 Revenue Percent of total revenue
Department of Veterans Affairs $35,898 35.1% $33,344 50.2%
Department of Health and Human Services 44,536 43.6% 27,741 41.8%
Department of Defense 21,003 20.5% 8,272 12.5%
Department of Homeland Security 256 0.3% (4,908) (7.4)%
Other customers with less than 10% share of total revenue 548 0.5% 1,991 2.9%
Total revenue $102,241 100.0% $66,440 100.0%

We provide solutions to three market focus areas: Defense and Veteran Health Solutions, Human Solutions and Services, and Public Health and Life Sciences. We deliver domain-specific expertise, industry best-practices and innovations to customers across these markets leveraging seven core competencies: secure data analytics, clinical trials and laboratory services, case management, performance evaluation, system modernization, operational logistics and readiness, and strategic digital communications. The Company manages its operations from its principal executive office in Atlanta, Georgia, and we have a complementary headquarters office in Silver Spring, Maryland. The Company employs over 3,200 skilled employees working throughout the United States and one location overseas.

Acquisitions

On December 8, 2022, we acquired Grove Resource Solutions, LLC. ("GRSi") to increase future organic growth, diversify our customer base, and to expand into adjacent markets. GRSi provides research and development, systems engineering and integration, and digital transformations solutions to federal agencies, notably the National Institutes of Health ("NIH"), U.S. Navy and U.S. Marine Corps. For further information, refer to Note 4 of the accompanying notes to our consolidated financial statements contained elsewhere in this report.

Major Contracts

We operate primarily through prime contracts awarded by the government through competitive bidding processes. We have a diverse mix of contract vehicles with various agencies of the United State government, which supports our overall corporate growth strategy. Our Federal contract schedules are renewed on a recurring basis for multi-year periods.

The revenue attributable to the VA was derived from 16 separate contracts covering the Company's performance of pharmacy and logistics services in support of the VA's Consolidated Mail Outpatient Pharmacy ("CMOP") program.

  • Nine contracts for pharmacy services, which represent revenues of approximately $60.6 million and $51.2 million for the nine months ended June 30, 2023 and 2022, respectively, are currently operating under a bridge contract through October 2023.
  • Seven contracts for logistics services, which represent approximately $43.7 million and $41.1 million of revenues for the nine months ended June 30, 2023 and 2022, respectively, are currently operating under a bridge contract through November 2023.

The VA has issued a request for proposal for healthcare logistics and pharmacy services for each CMOP location. The procurement was set-aside for a service-disabled veteran owned small business ("SDVOSB") to be solicited as the prime contractor. DLH maintains relationships with SDVOSB partners. Should the new contracts for performance of these services be awarded to a partner of DLH, the Company expects to continue to perform a significant amount of the contract’s volume of business as a subcontractor. Should the VA conclude that an award to an SDVOSB prime contractor is not in the best interest of the government, they may reissue a solicitation in an unrestricted competition. DLH believes that its service excellence over many years on the program would provide an advantage in an unrestricted competition.

The Company's contract with HHS in support of its Head Start program generated $27.1 million and $25.9 million of its revenue for the nine months ended June 30, 2023 and 2022, respectively. This contract has a period of performance through April 2025.

We remain dependent upon the continuation of our relationships with the VA and HHS. Our results of operations, cash flows, and financial condition would be materially adversely affected if we were unable to continue our relationship with either of these customers, if we were to lose any of our material current contracts, or if the amount of services we provide to them was to be materially reduced.

Backlog

At June 30, 2023, our backlog was approximately $817.8 million, of which $147.3 million was funded backlog. At September 30, 2022, our backlog was approximately $482.5 million, of which $98.9 million was funded backlog.

We define backlog as our estimate of remaining future revenue from existing signed contracts, assuming the exercise of all options relating to such contracts and including executed task orders issued under Indefinite Quantity/Indefinite Delivery ("IDIQ") contracts or if the contract is a single award IDIQ contract.

We define funded backlog as the portion of backlog for which funding is appropriated and allocated to the contract by the customer and authorized for payment by the customer, once specified work is completed. Funded backlog does not include the full contract value as Congress often appropriates funding for contracts on a yearly or quarterly basis.

Circumstances and events may cause changes in the amount of our backlog and funded backlog, including the execution of new contracts, extension of existing contracts, non-renewal or completion of current contracts, early termination, and adjustments to estimates. Changes in funded backlog may be affected by the funding cycles of the government. While no assurances can be given that existing contracts will result in earned revenue in any future period, or at all, our major customers have historically exercised their contractual renewal options.

Backlog value is quantified from management's judgment and assumptions about the volume of services based on past volume trends and current planning developed with customers.

Forward-Looking Business Trends

Our mission is to expand our position as a trusted provider of technology-enabled healthcare and public health services, medical logistics, and readiness enhancement services to active duty personnel, veterans, and civilian populations and communities. Our primary focus within the defense agency markets include military service members' and veterans' requirements for telehealth services, behavioral healthcare, medication therapy management, process management, clinical systems support, and healthcare delivery. Our primary focus within the civilian agency markets includes healthcare and social programs delivery and readiness. These include compliance monitoring on large scale programs, technology-enabled program management, consulting, and digital communications solutions ensuring that education, health, and social standards are being achieved within underserved and at-risk populations. We believe these business development priorities will position the Company to expand within top national priority programs and funded areas.

Federal budget outlook for 2024

On March 9, 2023, President Biden's administration released its budget request for fiscal year 2024. The administration's budget had several focus areas:

  • Lowering health care costs and expand access to healthcare
  • Expanding access to affordable, high-quality early child care and learning
  • Investing in cutting edge technologies
  • Improving our global security posture

While we believe that the services and capabilities we provide are key to the federal government executing its missions and meeting its strategic missions and goals, it is uncertain in any particular government fiscal year that appropriations bills will be passed. When appropriation bills have not passed, government agencies continue to operate under continuing resolutions. Over the coming months, we anticipate that the administration will negotiate with Congressional leaders to develop legislation that will fund the federal government's fiscal 2024 operations.

On June 3, 2023, the President signed H.R. 3746 "The Fiscal Responsibility Act" into law. This bill caps national defense spending at the President's Budget request levels of $886 billion and $895 billion for government fiscal year 2024 and 2025, respectively. The legislation also suspended the debt ceiling until January 1, 2025.

Adverse changes in fiscal and economic conditions could materially impact our business. Some changes that could have an adverse impact on our business include the implementation of future spending reductions (including sequestration), delayed passage of appropriations bills resulting in temporary or full-year continuing resolutions, extreme inflationary increases adversely impacting fixed-price contracts, inability to increase or suspend the Federal debt ceiling, and potential government shutdowns.

Industry consolidation among federal government contractors

There has been active consolidation and a strong increase in merger and acquisition activity among federal government contractors over the past few years that we expect to continue, fueled by public companies leveraging strong balance sheets. Companies often look to acquisitions that augment core capabilities, contracts, customers, market differentiators, stability, cost synergies, and higher margin and revenue streams.

Potential impact of Federal Contractual set-aside Laws and Regulations:

The Federal government has an overall goal of 23% of prime contracts flowing through small businesses. As previously reported, various agencies within the federal government have policies that support small business goals, including the adoption of the “Rule of Two” by the VA, which provides that the agency shall award contracts by restricting competition for the contract to service-disabled or other veteran owned businesses. To restrict competition pursuant to this rule, the contracting officer must reasonably expect that at least two of these businesses, which are capable of delivering the services, will submit offers and that the award can be made at a fair and reasonable price that offers best value to the United States. When two qualifying small businesses cannot be identified, the VA may proceed to award contracts following a full and open bid process.

The Company believes that its past performance in this market and track record of success provide a competitive advantage. However, the effect of set-aside provisions may limit our ability to compete for prime contractor positions on programs that we recompete or that we have targeted for growth. In these cases, the Company may elect to join a team with an eligible contractor as prime in support of such small businesses for specific pursuits that align with our core markets and corporate growth strategy.

Results of Operations

For the Three Months Ended June 30, 2023 as Compared to the Three Months Ended June 30, 2022

The following table summarizes, for the periods indicated, consolidated statements of operations data expressed in dollars in thousands except for per share amounts, and as a percentage of revenue as follows (in thousands and percent):

Consolidated Statements of Operations: Three Months Ended June 30, 2023 June 30, 2022 Change
Revenue $102,241 100.0% $66,440 100.0% $35,801
Cost of operations:
Contract costs 80,919 79.1% 49,668 74.9% 31,251
General and administrative costs 9,935 9.7% 7,535 11.3% 2,400
Corporate development costs — —% 250 0.3% (250)
Depreciation and amortization 4,280 4.2% 1,873 2.8% 2,407
Total operating costs 95,134 93.0% 59,326 89.3% 35,808
Income from operations 7,107 7.0% 7,114 10.7% (7)
Interest expense 4,917 4.9% 512 0.8% 4,405
Income before provision for income taxes 2,190 2.1% 6,602 9.9% (4,412)
Income tax expense 452 0.4% 1,738 2.6% (1,286)
Net income $1,738 1.7% $4,864 7.3% $(3,126)
Net income per share - basic $0.13 $0.38 $(0.25)
Net income per share - diluted $0.12 $0.34 $(0.22)

The following factors have affected our operating results for the third quarter of fiscal year 2023 as compared to the third quarter of our 2022 fiscal year:

  • During the quarter ended December 31, 2022, we acquired GRSi. From the date of this acquisition, we have received the benefit of additional revenue, as well as incurred additional operating costs. In addition, we amended and restated our credit facility to fund the acquisition of GRSi and the cost of servicing this debt has resulted in an increase in our interest expense.
  • Our results of operations for the quarter ended June 30, 2022 included revenues of approximately ($5.1) million derived from the two task orders awarded under a FEMA contact to support the State of Alaska in its response to the COVID-19 pandemic. These task orders were completed during the quarter ended March 31, 2022 and there was no comparable revenue contribution from this work during the 2023 period.

Due to these developments, in the “Non-GAAP Financial Measures” section below, we have included a discussion of our adjusted financial performance to present our financial performance for the quarters ended June 30, 2023 and 2022 without the impact of the FEMA task orders.

Revenue

Revenue for the quarter ended June 30, 2023 was $102.2 million, an increase of $35.8 million. The increase in revenue is primarily due to the $34.4 million revenue contribution from the acquisition of GRSi. The remaining increase was due to volume increase on legacy customer contracts.

Cost of Operations

Contract costs primarily include the costs associated with providing services to our customers. These costs are generally comprised of direct labor and associated fringe benefit costs, subcontract cost, other direct costs, and the related management and infrastructure costs. For the three months ended June 30, 2023, contract costs increased by approximately $31.3 million, principally due to the inclusion of GRSi.

General and administrative costs are for those employees not directly providing services to our customers, to include but not limited to executive management, bid and proposal, accounting, and human resources. These costs increased as compared to the prior fiscal year period by $2.4 million, primarily due to the inclusion of GRSi.

For the three months ended June 30, 2023, depreciation and amortization costs were approximately $0.2 million and $4.1 million, respectively, as compared to approximately $0.2 millions and $1.6 million for the prior fiscal year period, respectively. The increase in amortization was principally due to the acquired definite-lived intangible assets of GRSi.

Interest Expense

Interest expense includes items such as interest expense and amortization of deferred financing costs on debt obligations.

For the three months ended June 30, 2023 and 2022, interest expense was approximately $4.9 million and $0.5 million, respectively. The increase in interest expense was primarily due to the borrowing required to finance the GRSi acquisition.

Provision for Income Taxes

For the three months ended June 30, 2023 and 2022, DLH recorded a $0.4 million and $1.7 million provision for tax expense, respectively. The effective tax rate for the three months ended June 30, 2023 and 2022 was 23% and 26%, respectively.

Results of Operations for the Nine Months Ended June 30, 2023 and 2022

The following table summarizes, for the periods indicated, consolidated statements of operations data expressed in dollars in thousands except for per share amounts, and as a percentage of revenue:

Consolidated Statements of Operations: Nine Months Ended June 30, 2023 June 30, 2022 Change $
Revenue $274,385 100.0% $327,940 100.0% $(53,555)
Cost of operations:
Contract costs 216,779 79.0% 271,184 82.7% (54,405)
General and administrative costs 27,670 10.1% 22,178 6.8% 5,492
Corporate development costs 1,735 0.6% 250 0.1% 1,485
Depreciation and amortization 11,281 4.1% 5,740 1.7% 5,541
Total operating costs 257,465 93.8% 299,352 91.3% (41,887)
Income from operations 16,920 6.2% 28,588 8.7% (11,668)
Interest expense 11,512 4.2% 1,739 0.5% 9,773
Income before provision for income taxes 5,408 2.0% 26,849 8.2% (21,441)
Income tax expense 1,318 0.5% 7,003 2.1% (5,685)
Net income $4,090 1.5% $19,846 6.1% $(15,756)
Net income per share - basic $0.30 $1.55 $(1.25)
Net income per share - diluted $0.28 $1.40 $(1.12)

The following factors have affected our operating results for the nine months ended June 30, 2023 as compared to the same period in the 2022 fiscal year:

  • During the quarter ended December 31, 2022, we acquired GRSi. From the date of this acquisition, we have received the benefit of additional revenue, as well as incurred additional operating costs. In addition, we amended and restated

our credit facility to fund the acquisition of GRSi and the cost of servicing this debt has resulted in an increase in our interest expense.

  • Our results of operations for the nine months ended June 30, 2022 included revenues of approximately $125.8 million derived from the two task orders awarded under a FEMA contact to support the State of Alaska in its response to the COVID-19 pandemic. These task orders were completed during the quarter ended March 31, 2022 and there was no comparable revenue contribution from this work during the 2023 period.

Due to these developments, in the “Non-GAAP Financial Measures” section below, we have included a discussion of our adjusted financial performance to present our financial performance for the nine months ended June 30, 2023 and 2022 without the impacts of the FEMA task orders and including the corporate development costs associated with the GRSi acquisition.

Revenue

Revenue for the nine months ended June 30, 2023 was $274.4 million, a decrease of $53.6 million over the prior year period. The decrease in revenue is due primarily to the completion of two task orders awarded under a FEMA contract to support Alaska with its response to COVID-19. The revenue contribution from those task orders was $125.8 million. The decrease in revenue was partially offset by the contribution from GRSi of $73.9 million.

Cost of Operations

Contract costs primarily include the costs associated with providing services to our customers. These costs are generally comprised of direct labor and associated fringe benefit costs, subcontract cost, other direct costs, and the related management and infrastructure costs. For the nine months ended June 30, 2023, contract costs decreased by approximately $54.4 million principally due to the completion of two task orders awarded under a FEMA contract to support Alaska with its response to COVID-19.

General and administrative costs are for those employees not directly providing services to our customers, to include but not limited to executive management, bid and proposal, accounting, and human resources. These costs increased by approximately $5.5 million from the same period in the prior fiscal year. The increase was principally due to the inclusion of GRSi.

For the nine months ended June 30, 2023, depreciation and amortization costs were approximately $0.6 million and $10.7 million, respectively, as compared to approximately $0.8 million and $4.9 million for the prior fiscal year period, respectively.

Interest Expense, net

Interest expense, net, includes interest expense on the Company's term loan and amortization of deferred financing costs on debt obligations. For the nine months ended June 30, 2023 and 2022, interest expense, net was approximately $11.5 million and $1.7 million, respectively. The increase in interest expense was primarily due to the borrowing required to finance the GRSi acquisition.

Income Tax Expense

For the nine months ended June 30, 2023 and 2022, DLH recorded a $1.3 million and $7.0 million provision for tax expense, respectively. The effective tax rate for the nine months ended June 30, 2023 and 2022 was 23% and 26%, respectively.

Non-GAAP Financial Measures

The Company uses EBITDA and EBITDA Margin on Revenue as supplemental non-GAAP measures of performance. We define EBITDA as net income excluding (i) interest expense, (ii) provision for or benefit from income taxes and (iii) depreciation and amortization. EBITDA Margin on Revenue is EBITDA for the measurement period divided by revenue for the same period.

The Company is presenting additional non-GAAP measures regarding its financial performance for the three and nine months ended June 30, 2023. The measures presented are Adjusted Revenue, Adjusted Operating Income, Adjusted EBITDA, and Adjusted EBITDA Margin on Adjusted Revenue. In calculating these measures, we have added the corporate development costs associated with completing the GRSi acquisition to our results for fiscal year 2023 and we have removed the contribution from the FEMA task orders from the results for fiscal year 2022. These resulting measures present the quarterly financial performance compared to results delivered in the prior year period. Definitions of these additional non-GAAP measures are set forth below.

We have prepared these additional non-GAAP measures to eliminate the impact of items that we do not consider indicative of ongoing operating performance due to their inherent unusual or extraordinary nature. These non-GAAP measures of performance are used by management to conduct and evaluate its business during its review of operating results for the periods presented. Management and the Company's Board utilize these non-GAAP measures to make decisions about the use of the Company's resources, analyze performance between periods, develop internal projections and measure management performance. We believe that these non-GAAP measures are useful to investors in evaluating the Company's ongoing operating and financial results and understanding how such results compare with the Company's historical performance.

These supplemental performance measurements may vary from and may not be comparable to similarly titled measures by other companies in our industry. Adjusted Revenue, Adjusted Operating Income, EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue, and Adjusted EBITDA Margin on Adjusted Revenue are not recognized measurements under accounting principles generally accepted in the United States, or GAAP, and when analyzing our performance investors should (i) evaluate each adjustment in our reconciliation to the nearest GAAP financial measures and (ii) use the aforementioned non-GAAP measures in addition to, and not as an alternative to, revenue, operating income, net income or diluted EPS, as measures of operating results, each as defined under GAAP. We have defined these non-GAAP measures as follows:

“Adjusted Revenue” represents revenue less the contribution to revenue from the short-term FEMA task orders

“Adjusted Operating Income” represents operating income plus the corporate development costs associated with completing the GRSi acquisition incurred in fiscal 2023 less the contribution from the FEMA task orders, which occurred in fiscal 2022.

“Adjusted EBITDA” represents net income before income taxes, interest, depreciation and amortization and the corporate costs associated with completing the acquisition, less the contribution from FEMA task orders. “Adjusted EBITDA Margin on Adjusted Revenue” is calculated as Adjusted EBITDA divided by Adjusted Revenue.

Below is a reconciliation of Adjusted Revenue, Adjusted Operating Income, EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue and Adjusted EBITDA Margin on Adjusted Revenue reported for the three and nine months ended June 30, 2023 and 2022 compared to the most directly comparable financial measure calculated and presented in accordance with GAAP as follows (in thousands except for per share amounts):

Adjusted Revenue Three Months Ended June 30, 2023 2022 Change Nine Months Ended June 30, 2023 2022 Change
Revenue $102,241 $66,440 $35,801 $274,385 $327,940 $(53,555)
Less: FEMA task orders to support Alaska (a) — (5,116) 5,116 — 125,773 (125,773)
Adjusted Revenue $102,241 $71,556 $30,685 $274,385 $202,167 $72,218
Adjusted Operating Income
Operating Income $7,107 $7,114 $(7) $16,920 $28,588 $(11,668)
Corporate development costs (b) — — — 1,735 — 1,735
Less: FEMA task orders to support Alaska (c) — 608 (608) — 12,479 (12,479)
Adjusted Operating Income $7,107 $6,506 $601 $18,655 $16,109 $2,546
EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue & Adjusted EBITDA Margin on Adjusted Revenue
Net Income $1,738 $4,864 $(3,126) $4,090 $19,846 $(15,756)
Depreciation and amortization 4,280 1,873 2,407 11,281 5,740 5,541
Interest expense 4,917 512 4,405 11,512 1,739 9,773
Income tax expense 452 1,738 (1,286) 1,319 7,003 (5,684)
EBITDA $11,387 $8,987 $2,400 $28,202 $34,328 $(6,126)
Corporate development costs (b) — $— — 1,735 — 1,735
Less: FEMA task order to support Alaska (c) — 608 (608) — 12,479 (12,479)
Adjusted EBITDA $11,387 $8,379 $3,008 $29,937 $21,849 $8,088
Net income margin on Revenue 1.7% 7.3% 1.5% 6.1%
EBITDA Margin on Revenue 11.1% 13.5% 10.3% 10.5%
Adjusted EBITDA Margin on Adjusted Revenue 11.1% 11.7% 10.9% 10.8%

(a): Represents revenue adjusted to exclude revenue from the short-term FEMA task orders during the three and nine months ended June 30, 2022.

(b): Represents corporate development costs we incurred to complete the GRSi transaction. These costs primarily include legal counsel, financial due diligence, customer market analysis and representation and warranty insurance premiums.

(c): Adjusted operating income represents the Company’s consolidated operating income, determined in accordance with GAAP, adjusted to add the corporate development costs associated with the GRSi acquisition for fiscal year 2023 and adjusted to exclude the operating income derived from the FEMA task orders. Operating income for the FEMA task orders is derived by subtracting from the revenue attributable to such task orders during the three months ended June 30, 2022 of ($5.1) million contract costs of ($5.7) million . Similarly, for the nine months ended June 30, 2022 operating income for the FEMA task orders is derived by subtracting from the revenue attributable to the tasks orders of $125.8 million the following amounts associated with such task orders: contract costs $112.1 million and general & administrative costs of $1.2 million.

Liquidity and capital management

As of June 30, 2023, the Company's immediate sources of liquidity include cash generated from operations, accounts receivable, and access to its secured revolving line of credit facility. This credit facility provides us with access of up to $70.0 million, subject to certain conditions including eligible accounts receivable. As of June 30, 2023, we have $32.9 million of available borrowing capacity on the revolving line of credit and have an outstanding balance of $16.4 million.

The Company's present operating liabilities are largely predictable and consist of vendor and payroll related obligations. We maintain cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000. Deposits held with financial institutions may exceed the $250,000 limit. DLH has not experienced any loss or denied any access to funds as a result of holding amounts in our bank accounts in excess to the FDIC limit. Our current investment and financing obligations are adequately satisfied by cash generated from operations and through access to our credit facility. Cash provided by operating activities is expected to be sufficient to support the Company's capital requirements and debt reduction goals.

A summary of the change in cash is presented below for the nine months ended June 30, 2023 and 2022 as follows (in thousands):

2023 2022
Net cash provided by (used in) operating activities $14,997 $(4,759)
Net cash used in investing activities (181,291) (244)
Net cash provided by (used in) financing activities 166,596 (17,988)
Net change in cash $302 $(22,991)

The cash used in investing activities was primarily due to the acquisition of GRSi and the purchase of capital assets purchased during the nine months ended June 30, 2023. Cash provided by financing activities was $166.6 million during the nine months ended June 30, 2023 and were deployed to finance the GRSi acquisition. We intend to continue using cash to make mandatory and voluntary debt prepayments in future quarters subject to available cash.

Sources of cash

As of June 30, 2023, our immediate sources of liquidity include cash of approximately $0.5 million, accounts receivable, and access to our secured revolving line of credit facility. This credit facility provides us with access of up to $70.0 million, subject to certain conditions including eligible accounts receivable. As of June 30, 2023, we had unused borrowing capacity of $32.9 million, which is net of outstanding letters of credit. The Company's present operating liabilities are largely predictable and consist of vendor and payroll related obligations. We believe that our current investment and financing obligations are adequately covered by cash generated from profitable operations and that planned operating cash flow should be sufficient to support our operations for twelve months from the date of issuance of these consolidated financial statements.

Credit Facilities

A summary of our credit facilities for the period ended June 30, 2023 is as follows (in millions):

Arrangement Loan Balance Interest* Maturity Date
Secured term loan (a) due December 8, 2027 $179.3 SOFR* + 4.2% December 8, 2027
Secured revolving line of credit (b) due December 8, 2027 $16.4 SOFR* + 4.2% December 8, 2027

*SOFR as of June 30, 2023 was 5.2%

On September 30, 2019, we executed a floating-to-fixed interest rate swap with First National Bank ("FNB") as counter-party. The notional amount in the floating-to-fixed interest rate swap as of June 30, 2023 is $16.2 million matures in 2024, and the fixed rate is 1.61%. On January 31, 2023, we executed an additional floating-to-fixed interest rate swap with FNB; the notional amount as of June 30, 2023 is $96.0 million, it matures in January 2026, and the fixed rate is 4.1%. The total floating-to-fixed swap balance as of June 30, 2023 is $112.2 million.

(a) Represents the principal amounts payable on our term loan, which is secured by liens on substantially all of the assets of the Company. The principal of the term loan is payable in quarterly installments with the remaining balance due on December 8, 2027.

(b) The secured revolving line of credit has a ceiling of up to $70.0 million and a maturity date of December 8, 2027. The Company has accessed funds from the revolving credit facility during the quarter and has a balance outstanding at June 30, 2023 of $16.4 million

The secured term loan and secured revolving line of credit are secured by liens on substantially all of the assets of the Company. The provisions of our credit facilities are fully described in Note 8 to the consolidated financial statements.

Contractual Obligations as of June 30, 2023

(in thousands)

Total Payments Due by Period Next 12 Months 2-3 Years 4-5 Years More than 5 Years
Debt obligations $195,760 $14,250 $36,813 $144,697 $—
Facility operating leases 24,636 3,501 7,963 5,668 7,504
Equipment operating leases 67 17 50 — —
Total contractual obligations $220,463 $17,768 $44,826 $150,365 $7,504

Critical Accounting Policies and Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include valuation of goodwill and intangible assets, stock-based compensation, and measurement of loss development on workers' compensation claims. In addition, the Company estimates overhead charges and allocates such charges throughout the year. Actual results could differ from those estimates. For a detailed discussion on the application of these and other accounting policies, you should review the discussion under the caption Significant Accounting Policies in Note 2 of the notes to our consolidated financial statements contained elsewhere in this report.

Revenue Recognition

We recognize revenue over time when there is a continuous transfer of control to our customer. For our U.S. government contracts, this continuous transfer of control to the customer is supported by clauses in the contract that allow the U.S. government to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit, and take control of any work in process. When control is transferred over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. For services contracts, we satisfy our performance obligations as services are rendered. We use cost-based input and time-based output methods to measure progress.

For time and materials contracts, revenue is recognized to the extent of billable rates times hours delivered plus materials and other reimbursable costs incurred. Revenue for cost reimbursable contracts is recorded as reimbursable costs are incurred, including an estimated share of the applicable contractual fees earned. For firm fixed price contracts, the consideration received for our performance is set at a predetermined price. Revenue for our firm fixed price contracts is recognized over time using a straight-line measure of progress. Contract costs are expensed as incurred. Estimated losses are recognized when identified.

Refer to Note 5 of the accompanying notes to our consolidated financial statements contained elsewhere in this report.

Long-lived Assets

Our long-lived assets include equipment and improvements, right-of-use assets, intangible assets, and goodwill. The Company continues to review its long-lived assets for possible impairment or loss of value at least annually or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit’s carrying amount is greater than its fair value.

Equipment and improvements are stated at cost. Depreciation and amortization are provided using the straight-line method over the estimated useful asset lives (3 to 7 years) and the shorter of the initial lease term or estimated useful life for leasehold improvements.

Costs incurred to place the asset in service are capitalized and costs incurred after implementation are expensed. Amortization expense is recorded when the software is placed in service on a straight-line basis over the estimated useful life of the software.

Right-of-use assets are measured at the present value of future minimum lease payments, including all probable renewals, plus lease payments made to the lessor before or at lease commencement and indirect costs, less incentives received. Our right-of-use assets include long-term leases for facilities and equipment and are amortized over their respective lease terms.

Intangible assets are originally recorded at fair value and amortized on a straight-line basis over their assessed useful lives. The assessed useful lives of the assets are 10 years.

Goodwill

The Company continues to review its goodwill for possible impairment or loss of value at least annually or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit’s carrying amount is greater than its fair value. Based on the results of the work performed, the Company has concluded that no impairment loss was warranted, as no change in business conditions occurred which would have a material adverse effect on the valuation of goodwill.

Our assessment incorporated effects of the COVID-19 pandemic, which did not have a meaningful impact on our financial results. Notwithstanding this evaluation, factors including non-renewal of a major contract or other substantial changes in business conditions could have a material adverse effect on the valuation of goodwill in future periods and the resulting charge could be material to future periods’ results of operations.

Provision for Income Taxes

The Company accounts for income taxes in accordance with the liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reflected on the consolidated balance sheet when it is determined that it is more likely than not that the asset will be realized. This guidance also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax asset will not be realized. The Company has fully utilized its net operating loss carryforwards.

Stock-based Equity Compensation

The Company uses the fair value-based method for stock-based compensation. Options issued are designated as either an incentive stock or a non-statutory stock option. No option may be granted with a term of more than 10 years from the date of grant. Option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued common shares. All awards to employees and non-employees are recorded at fair value on the date of the grant and expensed over the period of vesting. The Company uses a Monte Carlo method to estimate the fair value of each stock option at the date of grant. Any consideration paid by the option holders to purchase shares is credited to capital stock.

Market risk

As filed, 1,436 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Except as described elsewhere in this report, the Company has not engaged in trading practices in securities or other financial instruments and therefore does not have any material exposure to interest rate risk, foreign currency exchange rate risk, commodity price risk or other similar risks, which might otherwise result from such practices. The Company has limited foreign operations and therefore is not materially subject to fluctuations in foreign exchange rates, commodity prices or other market rates or prices from market sensitive instruments. On September 30, 2019, we executed a floating-to-fixed interest rate swap with FNB as counter-party. The notional amount in the floating-to-fixed interest rate swap is $16.2 million for the current quarter and the remaining outstanding balance of our secured term loan is subject to interest rate fluctuations. On January 31, 2023, we executed an additional floating-to-fixed interest rate swap with FNB; the notional amount as of June 30, 2023 is $96.0 million, it matures in January 2026, and the fixed rate is 4.1% The total notional amount for all the interest rate swaps is currently $112.2 million with the remaining balance of debt subject to floating interest rates.

We have determined that a 1.0% increase to SOFR would impact our interest expense by approximately $0.8 million per year. As of June 30, 2023, the interest rate on the floating interest rate debt was 9.3%.

Controls and procedures

As filed, 2,507 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Our CEO and President and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based on the evaluation of these controls and procedures, our disclosure controls and procedures were effective at the reasonable assurance level to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 (i) is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (ii) that such information is accumulated and communicated to our management, including our CEO and President and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Our management, including our CEO and President and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. Our management, however, believes our disclosure controls and procedures are in fact effective to provide reasonable assurance that the objectives of the control system are met.

Changes in Internal Control over Financial Reporting

With the exception of the matter described below there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934) identified in connection with the evaluation of our internal controls that occurred during the fiscal quarter ended June 30, 2023, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

In December 2022, we acquired Grove Resource Solutions, LLC and are in the process of integrating this business into our existing control environment.

Risk factors

As filed, 1,521 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our operating results and financial condition have varied in the past and may in the future vary significantly depending on a number of factors. In addition to the other information set forth in this report, you should carefully consider the factors discussed in the “Risk Factors” section in our Annual Report on Form 10-K for the year ended September 30, 2022, in our Quarterly Report on Form 10-Q for the quarter ended December 31, 2022, and in our other reports filed with the SEC concerning the risks associated with our business, financial condition and results of operations. These factors, among others, could materially and adversely affect our business, results of operations, financial condition or liquidity and cause our actual results to differ materially from those contained in statements made in this report and presented elsewhere by management from time to time. The risks we have identified in our reports are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently believe are immaterial may also materially adversely affect our business, results of operations, financial condition or liquidity. See Item 1A, Risk Factors, in our Annual Report on Form 10-K for the fiscal year ended September 30, 2022. We believe that there have been no material changes from the risk factors described in our Annual Report on Form 10-K for the fiscal year ended September 30, 2022 and our Quarterly Report on Form 10-Q for the quarter ended December 31, 2022.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-04-01 to 2023-06-30$102.2mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Revenue9 months2022-10-01 to 2023-06-30$274.4mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Operating income3 months2023-04-01 to 2023-06-30$7.1mus-gaap:OperatingIncomeLoss
Operating income9 months2022-10-01 to 2023-06-30$16.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2023-04-01 to 2023-06-30$4.3mus-gaap:InterestExpense
Interest expense9 months2022-10-01 to 2023-06-30$10.0mus-gaap:InterestExpense
Income tax3 months2023-04-01 to 2023-06-30$452.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2022-10-01 to 2023-06-30$1.3mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-04-01 to 2023-06-30$1.7mus-gaap:ProfitLoss
Net income9 months2022-10-01 to 2023-06-30$4.1mus-gaap:ProfitLoss
Diluted EPS3 months2023-04-01 to 2023-06-30$0.12us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2022-10-01 to 2023-06-30$0.28us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-04-01 to 2023-06-30$0.13us-gaap:EarningsPerShareBasic
Basic EPS9 months2022-10-01 to 2023-06-30$0.30us-gaap:EarningsPerShareBasic
Operating cash flow9 months2022-10-01 to 2023-06-30$15.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2022-10-01 to 2023-06-30$580.0kus-gaap:PaymentsToAcquireProductiveAssets
Cash and equivalentsAt period end2023-06-30$530.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-06-30$72.5mus-gaap:AssetsCurrent
Total assetsAt period end2023-06-30$359.4mus-gaap:Assets
Current liabilitiesAt period end2023-06-30$75.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-06-30$254.2mus-gaap:Liabilities
Long-term debtAt period end2023-06-30$188.1mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2023-06-30$28.7mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2023-06-30$105.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000785557-23-000053. Last ingested by Listed: Oct 27, 2026, 17:13 ET. Listed shows no prices and gives no investment advice.